Literature DB >> 18812441

Vocal cord paresis and diaphragmatic dysfunction are severe and frequent symptoms of GDAP1-associated neuropathy.

Teresa Sevilla1, Teresa Jaijo, Dolores Nauffal, Diego Collado, María José Chumillas, Juan J Vilchez, Nuria Muelas, Luis Bataller, Rosalía Domenech, Carmen Espinós, Francesc Palau.   

Abstract

Cranial nerve involvement in Charcot-Marie-Tooth disease (CMT) is rare, though there are a number of CMT syndromes in which vocal cord paralysis is a characteristic feature. CMT disease due to mutations in the ganglioside-induced differentiation-associated protein 1 gene (GDAP1) has been reported to be associated with vocal cord and diaphragmatic palsy. In order to address the prevalence of these complications in patients with GDAP1 mutations we evaluated vocal cord and respiratory function in nine patients from eight unrelated families with this disorder. Hoarseness of the voice and inability to speak loudly were reported by eight patients and one had associated symptoms of respiratory insufficiency. Patients were investigated by means of peripheral and phrenic nerve conduction studies, flexible laryngoscopy, pulmonary function studies and polysomnography. Nerve conduction velocities and pathological studies were compatible with axonal CMT (CMT2). Flexible laryngoscopy showed left vocal cord palsy in four cases, bilateral cord palsies in four cases and was normal in one case. Restrictive respiratory dysfunction was seen in the eight patients with vocal cord paresis who were all chair-bound. These eight had confirmed phrenic nerve dysfunction on neurophysiology evaluation. The patient with normal vocal cord and pulmonary function had a less severe clinical course.This study shows that CMT patients with GDAP1 mutations develop severe disability due to weakness of limb muscles and that laryngeal and respiratory muscle involvement occurs late in the disease process when significant proximal upper limb weakness has developed. The early and predominant involvement of the left vocal cord innervated by the longer left recurrent laryngeal nerve suggests a length dependent pattern of nerve degeneration. In GDAP1 neuropathy, respiratory function should be thoroughly investigated because life expectancy can be compromised due to respiratory failure.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18812441     DOI: 10.1093/brain/awn228

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  22 in total

Review 1.  Sleep apnea in pediatric neurological conditions.

Authors:  Gabor Szuhay; Josh Rotenberg
Journal:  Curr Neurol Neurosci Rep       Date:  2009-03       Impact factor: 5.081

2.  Charcot-Marie-Tooth disease: genetic and clinical spectrum in a Spanish clinical series.

Authors:  Rafael Sivera; Teresa Sevilla; Juan Jesús Vílchez; Dolores Martínez-Rubio; María José Chumillas; Juan Francisco Vázquez; Nuria Muelas; Luis Bataller; José María Millán; Fancesc Palau; Carmen Espinós
Journal:  Neurology       Date:  2013-09-27       Impact factor: 9.910

3.  Histopathology of the Inner Ear in Charcot-Marie-Tooth Syndrome Caused by a Missense Variant (p.Thr65Ala) in the MPZ Gene.

Authors:  Joseph B Nadol; E Tessa Hedley-Whyte; Sami Samir Amr; Jennifer T O Apos Malley; Takefumi Kamakura
Journal:  Audiol Neurootol       Date:  2019-01-24       Impact factor: 1.854

Review 4.  Intermediate Charcot-Marie-Tooth disease: an electrophysiological reappraisal and systematic review.

Authors:  José Berciano; Antonio García; Elena Gallardo; Kristien Peeters; Ana L Pelayo-Negro; Silvia Álvarez-Paradelo; José Gazulla; Miriam Martínez-Tames; Jon Infante; Albena Jordanova
Journal:  J Neurol       Date:  2017-03-31       Impact factor: 4.849

5.  CMT2C with vocal cord paresis associated with short stature and mutations in the TRPV4 gene.

Authors:  D-H Chen; Y Sul; M Weiss; A Hillel; H Lipe; J Wolff; M Matsushita; W Raskind; T Bird
Journal:  Neurology       Date:  2010-11-30       Impact factor: 9.910

Review 6.  Recent advances in the genetics of hereditary axonal sensory-motor neuropathies type 2.

Authors:  Senda Ajroud-Driss; Han-Xiang Deng; Teepu Siddique
Journal:  Curr Neurol Neurosci Rep       Date:  2011-06       Impact factor: 5.081

7.  Dominant GDAP1 founder mutation is a common cause of axonal Charcot-Marie-Tooth disease in Finland.

Authors:  Mari Auranen; Emil Ylikallio; Jussi Toppila; Mirja Somer; Sari Kiuru-Enari; Henna Tyynismaa
Journal:  Neurogenetics       Date:  2013-03-03       Impact factor: 2.660

8.  Late-onset Charcot-Marie-Tooth disease 4F caused by periaxin gene mutation.

Authors:  Shoko Tokunaga; Akihiro Hashiguchi; Akiko Yoshimura; Kengo Maeda; Takashi Suzuki; Hiroyo Haruki; Tomonori Nakamura; Yuji Okamoto; Hiroshi Takashima
Journal:  Neurogenetics       Date:  2012-08-01       Impact factor: 2.660

9.  Genotype-phenotype correlation and frequency of distribution in a cohort of Chinese Charcot-Marie-Tooth patients associated with GDAP1 mutations.

Authors:  Pukar Singh Pakhrin; Yongzhi Xie; Zhengmao Hu; Xiaobo Li; Lei Liu; Shunxiang Huang; Binghao Wang; Zihan Yang; Jiejun Zhang; Xin Liu; Kun Xia; Beisha Tang; Ruxu Zhang
Journal:  J Neurol       Date:  2018-01-25       Impact factor: 4.849

10.  Novel GDAP1 mutation in a Turkish family with CMT2K (CMT2K with novel GDAP1 mutation).

Authors:  Nilufer Sahin-Calapoglu; Meliha Tan; Mustafa Soyoz; Mustafa Calapoglu; Nurten Ozcelik
Journal:  Neuromolecular Med       Date:  2009-04-19       Impact factor: 3.843

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.